Related Experiment Videos
Electron spin resonance studies of erythrocyte ghost cells in Huntington's chorea
Insights
Electron spin resonance (ESR) studies did not detect membrane abnormalities in Huntington's Chorea (HC) patients. This technique, using the MAL-6 probe, is unreliable for diagnosing HC or identifying carriers.
Area of Science:
- Neurodegenerative Diseases
- Biochemistry
- Medical Diagnostics
Background:
- Huntington's Chorea (HC) is an autosomal dominant disease linked to potential generalized membrane abnormalities in peripheral tissues.
- Previous studies suggested Electron Spin Resonance (ESR) could detect differences between HC patients and controls.
Purpose of the Study:
- To investigate the reliability of the ESR technique in differentiating Huntington's Chorea patients from healthy controls.
- To assess the utility of ESR with the MAL-6 spin probe for diagnosing HC and identifying carriers.
Main Methods:
- Controlled, blind studies were conducted using the ESR technique.
- The spin probe 4-maleimido-2,2,6,6-tetramethylpiperidinooxyl (MAL-6) was incorporated into erythrocyte ghost cell membranes.
- Spectra were analyzed from 22 HC patients and 47 controls across two series.
Main Results:
- No significant differences were detected in ESR spectra between Huntington's Chorea patients and control individuals.
- The ESR technique, with the MAL-6 probe, failed to show reliable differentiation.
Conclusions:
- The ESR technique using the MAL-6 probe is not a sufficiently reliable method for diagnosing Huntington's Chorea.
- This method is unsuitable for the diagnosis of potential carriers of the Huntington's Chorea gene.
Abstract:
There is accumulated evidence which suggests that the primary gene defect in the autosomal dominant disease of Huntington's Chorea, is given expression as a generalised membrane abnormality in peripheral tissues. Several publications claim to be able to detect a difference between HC patients and controls by means of the electron spin resonance (ESR) technique. We have examined the electron spin resonance spectra of the spin probe 4-maleimido-2,2,6,6-tetramethylpiperidinooxyl (MAL-6) when incorporated into the membranes of erythrocyte ghost cells of 22 patients with HC and 47 controls, in 2 series of controlled, blind studies and we were unable to detect any difference between HC patients and normals. We conclude that the ESR technique with the probe used is not a sufficiently reliable test for accurate differentiation of HC patients from controls and is certainly not suitable as a method for the diagnosis of potential carriers of this disease.